Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Aaron C Tan"'
Autor:
Mustafa Khasraw, Susan M Chang, Amy B Heimberger, Michael Lim, John Simes, Solmaz Sahebjam, Michael Platten, Wolfgang Wick, David M Ashley, Patrick Y Wen, Aaron C Tan, Stephen J Bagley, Howard Colman, Evanthia Galanis, Alireza Mansouri, Simon Khagi, Minesh P Mehta, Vinay K Puduvalli, Scott J Antonia, Don Berry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
With rapid advances in our understanding of cancer, there is an expanding number of potential novel combination therapies, including novel–novel combinations. Identifying which combinations are appropriate and in which subpopulations are among the
Externí odkaz:
https://doaj.org/article/5fb3fb4dbf464e6b9e23b9714b84f3ae
Autor:
Stephanie P.L. Saw, MRCP, Gek San Tan, MSc, Wei Chong Tan, MRCP, Aaron C. Tan, PhD, Gillianne G.Y. Lai, MRCP, Darren W.T. Lim, MRCP, Ravindran Kanesvaran, MRCP, Wan Ling Tan, MRCP, Sze Huey Tan, PhD, Kiat Hon Lim, FRCPA, Anders J. Skanderup, PhD, Daniel S.W. Tan, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100599- (2023)
Introduction: To compare the performance of droplet digital polymerase chain reaction (ddPCR) and plasma next-generation sequencing (NGS) in detecting clearance of plasma EGFR (pEGFR) mutations. Methods: Patients with treatment-naive advanced EGFR-mu
Externí odkaz:
https://doaj.org/article/95ba3defcb024f6c832156416fd09357
Autor:
Tira J. Tan, W. X. Gladys Ang, Who-Whong Wang, Hui-Shan Chong, Sze Huey Tan, Rachael Cheong, John Whay-Kuang Chia, Nicholas L. Syn, Wai Ho Shuen, Rebecca Ba, Nivashini Kaliaperumal, Bijin Au, Richard Hopkins, Xinhua Li, Aaron C. Tan, Amanda O. L. Seet, John E. Connolly, Thaschawee Arkachaisri, Valerie Chew, Ahmad bin Mohamed Lajam, Dianyan Guo, Marvin Z. W. Chew, Martin Wasser, Pavanish Kumar, Salvatore Albani, Han Chong Toh
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Ad-sig-hMUC1/ecdCD40L is a recombinant adenovirus vaccine comprising human MUC1 antigen fused to the extracellular domain of the CD40 ligand. Here the authors report the result of a phase I clinical trial of Ad-sig-hMUC1/ecdCD40L in patients with adv
Externí odkaz:
https://doaj.org/article/bc9966f3f06642699fbd9cc02be4f7e3
Autor:
Aaron C. Tan
Publikováno v:
Thoracic Cancer, Vol 11, Iss 3, Pp 511-518 (2020)
The traditional classification of lung cancer into small cell lung cancer and non‐small cell lung cancer (NSCLC) has been transformed with the increased understanding of the molecular alterations and genomic biomarkers that drive the development of
Externí odkaz:
https://doaj.org/article/0bde963b777c4b72a10f818249e41701
Autor:
Alex Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, Jennifer Durling, Eric S. Lipp, Aaron C. Tan, Kyle M. Walsh, Brent A. Hanks, Margaret Johnson, Amanda E.D. Van Swearingen, Carey K. Anders, David M. Ashley, Mustafa Khasraw
Publikováno v:
Clinical Cancer Research. 29:1670-1677
For three years, COVID-19 has circulated among our communities and around the world, fundamentally changing social interactions, health care systems, and service delivery. For people living with (and receiving treatment for) cancer, pandemic conditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96b83faf23b6dae3f0915b751a837db9
https://doi.org/10.1158/1078-0432.ccr-23-0151
https://doi.org/10.1158/1078-0432.ccr-23-0151
Publikováno v:
Expert Review of Anticancer Therapy. 23:117-120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::253c1c35e9bf76781520b5fa869ea807
https://doi.org/10.1080/14737140.2023.2152795
https://doi.org/10.1080/14737140.2023.2152795
Autor:
Aaron C. Tan
Publikováno v:
Onco. 2:181-185
The discovery of therapeutically targetable oncogenic driver alterations has led to marked improvements in NSCLC outcomes. Targeted agents have been approved for an expanding list of biomarkers. Consequently, the accurate and timely identification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5504d74ec10f1aa3905ac15f3d4163
https://doi.org/10.3390/onco2030012
https://doi.org/10.3390/onco2030012
Autor:
Daniel S.W. Tan, Anders J. Skanderup, Axel M. Hillmer, Weiwei Zhai, Eng-Huat Tan, Wai Leong Tam, N. Gopalakrishna Iyer, Wan-Teck Lim, Chee Keong Toh, Lisda Suteja, Ming Jie Lim, Alexis Jiaying Khng, Audrey S.M. Teo, Lanying Wang, Yin Yeng Lee, Bien Soo Tan, Ghee Chee Phua, Devanand Anantham, Tanujaa Rajasekaran, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Chow Wei Too, Apoorva Gogna, Wan Ling Tan, Amit Jain, Irfahan Kassam, Marjan Mojtabavi Naeini, Kiat Hon Lim, Joe P.S. Yeong, Zaw Win Aung, Gillianne G.Y. Lai, Neha Rohatgi, Rahul Nahar, Jacob J.S. Alvarez, Angela Takano, Aaron C. Tan, Yvonne H.F. Teng, Khi Pin Chua
Supplementary Data from Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166d4b020fca17d01eb4115553cc3afd
https://doi.org/10.1158/1078-0432.22480715
https://doi.org/10.1158/1078-0432.22480715
Autor:
Daniel S.W. Tan, Anders J. Skanderup, Axel M. Hillmer, Weiwei Zhai, Eng-Huat Tan, Wai Leong Tam, N. Gopalakrishna Iyer, Wan-Teck Lim, Chee Keong Toh, Lisda Suteja, Ming Jie Lim, Alexis Jiaying Khng, Audrey S.M. Teo, Lanying Wang, Yin Yeng Lee, Bien Soo Tan, Ghee Chee Phua, Devanand Anantham, Tanujaa Rajasekaran, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Chow Wei Too, Apoorva Gogna, Wan Ling Tan, Amit Jain, Irfahan Kassam, Marjan Mojtabavi Naeini, Kiat Hon Lim, Joe P.S. Yeong, Zaw Win Aung, Gillianne G.Y. Lai, Neha Rohatgi, Rahul Nahar, Jacob J.S. Alvarez, Angela Takano, Aaron C. Tan, Yvonne H.F. Teng, Khi Pin Chua
Purpose:Despite the established role of EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated NSCLC, drug resistance inevitably ensues, with a paucity of treatment options especially in EGFRT790M-negative resistance.Experimental Design:We performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227b720107cfdf35e476c0479af15bbd
https://doi.org/10.1158/1078-0432.c.6530516.v1
https://doi.org/10.1158/1078-0432.c.6530516.v1
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 11 (2018)
Metastatic gastric cancer is associated with a poor prognosis and novel treatment options are desperately needed. The development of targeted therapies heralded a new era for the management of metastatic gastric cancer, however results from clinical
Externí odkaz:
https://doaj.org/article/9a692093305a4cda992cdb0aacb0a148